Onivyde

NDC 15054-0043 · Ipsen Biopharmaceuticals, Inc.

Generic nameIRINOTECAN HYDROCHLORIDE

Dosage formINJECTION, POWDER, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)IRINOTECAN HYDROCHLORIDE

Strength4.3 mg/mL

Pharmacologic classTopoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]

Marketing categoryNDA

Packages

15054-0043-1 — 1 VIAL, SINGLE-DOSE in 1 CARTON (15054-0043-1) / 10 mL in 1 VIAL, SINGLE-DOSE

Billed under HCPCS

J9205 — Injection, irinotecan liposome, 1 mg Medicare Part B payment limit (ASP + 6%): $65.86

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0009-0082 — irinotecan hydrochloride, 0009-0112 — irinotecan hydrochloride, 0009-7529 — irinotecan hydrochloride, 0143-9583 — Irinotecan Hydrochloride, 0143-9701 — Irinotecan Hydrochloride, 0143-9702 — Irinotecan Hydrochloride, 16714-027 — Irinotecan hydrochloride, 16714-131 — Irinotecan hydrochloride, 25021-230 — irinotecan hydrochloride, 45963-614 — Irinotecan hydrochloride, 50742-401 — Irinotecan Hydrochloride, 50742-402 — Irinotecan Hydrochloride, 55150-352 — IRINOTECAN HYDROCHLORIDE, 55150-353 — IRINOTECAN HYDROCHLORIDE, 55150-354 — IRINOTECAN HYDROCHLORIDE, 55150-355 — IRINOTECAN HYDROCHLORIDE, 60505-6128 — Irinotecan Hydrochloride, 60505-6272 — Irinotecan Hydrochloride, 61703-349 — Irinotecan Hydrochloride, 63323-193 — IRINOTECAN HYDROCHLORIDE, +8 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.